Table 1.
Mean (SD), median [IQR], or frequency (%) | CB (n = 423) | HB (n = 431) | p-value* |
---|---|---|---|
Age in years | 43.7 (9.97) | 44.4 (9.95) | 0.25 |
Gender | |||
Male | 242 (57.2%) | 244 (56.6%) | 0.74 |
MTF transgender | 5 (1.2%) | 3 (0.7%) | |
Female | 176 (41.6%) | 184 (42.7%) | |
Ethnicity† | |||
African American | 194 (45.9%) | 195 (45.2%) | < 0.01 |
Latino | 166 (39.2%) | 207 (48.0%) | |
Other | 63 (14.9%) | 29 (6.7%) | |
Insurance | |||
Public (e.g. Medicaid) | 329 (77.8%) | 386 (89.6%) | < 0.01 |
Commercial/private | 51 (12.1%) | 40 (9.3%) | |
Other/self-pay | 43 (10.2%) | 5 (1.2%) | |
Hospitalization within 3 months of first visit | |||
None | 301 (71.2%) | 281 (65.2%) | < 0.01 |
Montefiore Medical Center | 86 (20.3%) | 145 (33.6%) | |
Other hospital | 36 (8.5%) | 5 (1.2%) | |
HIV risk factor | |||
MSM | 57 (13.5%) | 64 (14.9%) | < 0.01 |
HSP | 206 (48.7%) | 248 (57.5%) | |
IDU | 100 (23.6%) | 85 (19.7%) | |
Other (incl. dual risk) or un- identified | 60 (14.2%) | 34 (7.9%) | |
Years since HIV diagnosis | 9 [3–15] | 10 [3–16] | 0.28 |
History of AIDS-defining condition | 195 (46.1%) | 251 (58.6%) | < 0.01 |
Initial CD4 [cells/mm3] | 437 (302.07) | 385 (357.23) | 0.02 |
Nadir CD4 [cells/mm3] | 311 (252.69) | 236 (236.12) | < 0.01 |
Hepatitis C co-infection | 144 (34.0%) | 129 (29.9%) | 0.20 |
Antiretroviral history | |||
Current | 165 (39.6%) | 176 (40.8%) | 0.75 |
Ever | 113 (27.1%) | 107 (24.8%) | |
None | 139 (33.3%) | 148 (34.3%) | |
Current illicit substance use | |||
Yes | 183 (43.3%) | 177 (41.1%) | 0.52 |
No/unknown | 240 (56.7%) | 254 (58.9%) | |
Current mental health co- morbidity | 201 (47.5%) | 198 (45.9%) | 0.64 |
Note:
p-values based on student’s t-test, Wilcoxon rank-sum test, or Pearson χ2
based on hospital administrative data
[abbreviations: SD = standard deviation; IQR = interquartile range; CB = community-based; HB = hospital-based; MTF = male-to-female; MSM = men who have sex with men; HSP = high-risk sexual partner; IDU = intravenous drug use]